18th Annual Meeting of the European Competence Network on Mastocytosis (ECNM)
Year 2020 Working Conference on Mast Cell Disorders
Annual ECNM Meeting: 27th to 29th August, 2020
Working Conference: 30th August to 1st September, 2020
Venue: Hilton Danube Hotel, Vienna
The three-day Annual Meeting of the European Competence Network on Mastocytosis (ECNM) took place in Vienna this year.
Due to the COVID-19 outbreak both the Annual ECNM Meeting and the Working Conference could be participated in via an online meeting platform as well as in person. Upholding COVID-related safety and social distancing measures was a challenge that was successfully mastered. It was the first time the dual mode was offered to participants and speakers and proved to be a great alternative for all those who were unable to travel to Vienna. 60 people participated in person, while around 100 joined via the online platform.
Peter Valent, and his team were proud to host this year’s meeting in a venue which is closely tied to the history of the ECNM as the very first Working Conference on Mastocytosis in the year 2000 and several other ECNM meetings took place right on the banks of the Danube river.
Karin Hartmann (University of Basel) was awarded the ECNM Researcher of the Year Award for her outstanding research on skin involvement in mastocytosis.
Presentations at the Annual Meeting covered many aspects of mastocytosis, including diagnosis of and prognostication in systemic mastocytosis, as well as the definition and management of mast cell activation and hereditary alpha tryptasemia.
In addition summaries of all ECNM Registry projects were presented and this year’s meeting was concluded with a session for patient associations where patients’ representatives could voice their views, experiences, and wishes.
The Working Conference focused on EU-US multicentre approaches to further standardise and refine parameters for disease diagnostics and treatment.
2020 Cell Therapies and Stem Cells in AML and CML
Date: 19th June, 2020
Venue: Online video format
In June 2020, a group of international researchers followed the invitation of the Medical University of Vienna and the LBI for Hematology and Oncology to discuss the newest developments in Cell Therapies and Stem Cells in AML and CML.
Due to the COVID-19 outbreak the meeting had to be changed to an online-only format on short notice, which was a premiere for the event organizers at the LBI HO. Nonetheless, the meeting was a great success and the online video format proved to work very well for all participants and speakers alike.
The one-day meeting included sessions on target expression profiles, stem cell transplantation, novel immunotherapy-concepts, and stem cell resistance. Further, updates on networking possibilities and co-operations were shared.